vimarsana.com
Home
Live Updates
Myovant: FDA Extends Review Of Myfembree In Pain Associated
Myovant: FDA Extends Review Of Myfembree In Pain Associated
Myovant: FDA Extends Review Of Myfembree In Pain Associated With Endometriosis To August 6
NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration has extended the review period for the supplemental New Drug Application or sNDA for Myfembree for the management of moderate to
Related Keywords
,
Pfizer Inc ,
Myovant Sciences ,
Drug Administration ,
New Drug Application ,
Prescription Drug User Fee Act ,
Myovant ,
Xtends ,
Review ,
Myfembree ,
Rain ,
Ssociated ,
Ith ,
Endometriosis ,
August ,